163 related articles for article (PubMed ID: 35965538)
21. Construction of an N6-methyladenosine lncRNA- and immune cell infiltration-related prognostic model in colorectal cancer.
Yu ZL; Zhu ZM
Protoplasma; 2022 Jul; 259(4):1029-1045. PubMed ID: 34734333
[TBL] [Abstract][Full Text] [Related]
22. Hub Long Noncoding RNAs with m6A Modification for Signatures and Prognostic Values in Kidney Renal Clear Cell Carcinoma.
Lin G; Wang H; Wu Y; Wang K; Li G
Front Mol Biosci; 2021; 8():682471. PubMed ID: 34295922
[No Abstract] [Full Text] [Related]
23. Contributions and Prognostic Values of N6-Methyladenosine RNA Methylation Regulators in Hepatocellular Carcinoma.
Qi LW; Jia JH; Jiang CH; Hu JM
Front Genet; 2020; 11():614566. PubMed ID: 33519919
[TBL] [Abstract][Full Text] [Related]
24. The m6A RNA Modification Quantity and the Prognostic Effect of Reader YTHDC2 in Colorectal Cancer.
Liu T; Tang W; Chen Y; Liu Y; Xu D; Jiang Y; Zhou S; Qin X; Ren L; Chang W; Xu J
Clin Med Insights Oncol; 2022; 16():11795549221104441. PubMed ID: 35898390
[TBL] [Abstract][Full Text] [Related]
25. A prognostic signature consisting of N6-methyladenosine modified mRNAs demonstrates clinical potential in prediction of biochemical recurrence and guidance on precision therapy in prostate cancer.
Lu J; Chen J; Lin Z; Liu Q; Zhong C; Cai Z; Jia Z; Zhong W; Liang Y; Cai C
Transl Oncol; 2023 Jul; 33():101670. PubMed ID: 37060728
[TBL] [Abstract][Full Text] [Related]
26. N6-methyladenosine Modification-Related Long Non-Coding RNAs are Potential Biomarkers for Predicting the Prognosis of Patients With Osteosarcoma.
Yang K; Wang F; Li K; Peng G; Yang H; Xu H; Xiang Y; Sun H
Technol Cancer Res Treat; 2022; 21():15330338221085354. PubMed ID: 35422168
[No Abstract] [Full Text] [Related]
27. Integrated Analysis of the Immune Infiltrates and PD-L1 Expression of N6-Methyladenosine-Related Long Non-Coding RNAs in Colorectal Cancer.
Jiang Z; Zhang Y; Chen K; Yang X; Liu J
Int J Gen Med; 2021; 14():5017-5028. PubMed ID: 34511985
[TBL] [Abstract][Full Text] [Related]
28. METTL3 promotes colorectal carcinoma progression by regulating the m6A-CRB3-Hippo axis.
Pan J; Liu F; Xiao X; Xu R; Dai L; Zhu M; Xu H; Xu Y; Zhao A; Zhou W; Dang Y; Ji G
J Exp Clin Cancer Res; 2022 Jan; 41(1):19. PubMed ID: 35012593
[TBL] [Abstract][Full Text] [Related]
29. Crosstalk between m6A mRNAs and m6A circRNAs and the time-specific biogenesis of m6A circRNAs after OGD/R in primary neurons.
Zhang C; Jian H; Shang S; Lu L; Lou Y; Kang Y; Bai H; Fu Z; Lv Y; Kong X; Li X; Feng S; Zhou H
Epigenetics; 2023 Dec; 18(1):2181575. PubMed ID: 36861189
[TBL] [Abstract][Full Text] [Related]
30. Hsa_circ_0004831 serves as a blood-based prognostic biomarker for colorectal cancer and its potentially circRNA-miRNA-mRNA regulatory network construction.
Xing L; Xia M; Jiao X; Fan L
Cancer Cell Int; 2020 Nov; 20(1):557. PubMed ID: 33292256
[TBL] [Abstract][Full Text] [Related]
31. Comprehensive analysis of the transcriptome-wide m6A methylome in colorectal cancer by MeRIP sequencing.
Zhang Z; Wang Q; Zhang M; Zhang W; Zhao L; Yang C; Wang B; Jiang K; Ye Y; Shen Z; Wang S
Epigenetics; 2021 Apr; 16(4):425-435. PubMed ID: 32749190
[TBL] [Abstract][Full Text] [Related]
32. SRSF9 promotes colorectal cancer progression via stabilizing DSN1 mRNA in an m6A-related manner.
Wang X; Lu X; Wang P; Chen Q; Xiong L; Tang M; Hong C; Lin X; Shi K; Liang L; Lin J
J Transl Med; 2022 May; 20(1):198. PubMed ID: 35509101
[TBL] [Abstract][Full Text] [Related]
33. Gene signature and prognostic merit of M6a regulators in colorectal cancer.
Zhang J; Cheng X; Wang J; Huang Y; Yuan J; Guo D
Exp Biol Med (Maywood); 2020 Sep; 245(15):1344-1354. PubMed ID: 32605475
[TBL] [Abstract][Full Text] [Related]
34. Construction of a circRNA-Related ceRNA Prognostic Regulatory Network in Breast Cancer.
Song H; Sun J; Kong W; Ji Y; Xu D; Wang J
Onco Targets Ther; 2020; 13():8347-8358. PubMed ID: 32922032
[TBL] [Abstract][Full Text] [Related]
35. Comprehensive analysis of lncRNAs N
Zuo L; Su H; Zhang Q; Wu WY; Zeng Y; Li XM; Xiong J; Chen LF; Zhou Y
Aging (Albany NY); 2021 Jan; 13(3):4182-4198. PubMed ID: 33493136
[TBL] [Abstract][Full Text] [Related]
36. Stabilization of UCA1 by N6-methyladenosine RNA methylation modification promotes colorectal cancer progression.
He RZ; Jiang J; Hu X; Lei M; Li J; Luo W; Duan L; Hu Z; Mo YY; Luo DX; Peng WX
Cancer Cell Int; 2021 Nov; 21(1):616. PubMed ID: 34809621
[TBL] [Abstract][Full Text] [Related]
37. N6-methyladenosine RNA methylation regulator-related alternative splicing gene signature as prognostic predictor and in immune microenvironment characterization of patients with low-grade glioma.
Maimaiti A; Tuersunniyazi A; Meng X; Pei Y; Ji W; Feng Z; Jiang L; Wang Z; Kasimu M; Wang Y; Shi X
Front Genet; 2022; 13():872186. PubMed ID: 35937991
[No Abstract] [Full Text] [Related]
38. N6-methyladenosine-induced circ1662 promotes metastasis of colorectal cancer by accelerating YAP1 nuclear localization.
Chen C; Yuan W; Zhou Q; Shao B; Guo Y; Wang W; Yang S; Guo Y; Zhao L; Dang Q; Yang X; Wang G; Kang Q; Ji Z; Liu J; Sun Z
Theranostics; 2021; 11(9):4298-4315. PubMed ID: 33754062
[TBL] [Abstract][Full Text] [Related]
39. Detailed profiling of m6A modified circRNAs and synergistic effects of circRNA and environmental risk factors for coronary artery disease.
Fu Y; He S; Li C; Gan X; Wang Y; Zhou Y; Jiang R; Zhang Q; Pan Y; Zhou H; Chen X; Jia E
Eur J Pharmacol; 2023 Jul; 951():175761. PubMed ID: 37169142
[TBL] [Abstract][Full Text] [Related]
40. Analysis of Circular RNA-Related Competing Endogenous RNA Identifies the Immune-Related Risk Signature for Colorectal Cancer.
Song W; Ren J; Wang C; Ge Y; Fu T
Front Genet; 2020; 11():505. PubMed ID: 32582276
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
